Rare diseases
Investigational molecules
Locations
Back to Portugal51 clinical trials in Santa Maria Da Feira, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
PortugalStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
PortugalStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PortugalStudy on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy
PortugalStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
PortugalStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
PortugalStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
PortugalStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
PortugalStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
PortugalStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
PortugalLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
PortugalStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Ongoing research evaluating novel treatments for multiple sclerosis and epilepsy, with studies focusing on both relapsing and progressive forms of MS, as well as various types of seizure disorders.
Multiple trials testing new compounds like tolebrutinib and fenebrutinib for long-term disease management.
Studies focusing on preventing cardiovascular events and managing atherosclerotic disease, with particular attention to high-risk patients and post-stroke care.
Innovative therapies being tested to reduce major adverse cardiovascular events and improve patient outcomes.
Research targeting inflammatory bowel diseases, including studies on Crohn's Disease and ulcerative colitis, testing new therapeutic approaches.
Evaluating combination therapies and novel compounds for moderate to severe disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
